Results 221 to 230 of about 95,261 (258)

Bcl-xL overexpression in T cells preserves muscle mitochondrial structure and function and prevents frailty in old mice. [PDF]

open access: yesSci Adv
Mas-Bargues C   +8 more
europepmc   +1 more source

A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. [PDF]

open access: yesNeoplasia
Han S   +10 more
europepmc   +1 more source

Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis. [PDF]

open access: yesCancer Lett
Zhang T   +19 more
europepmc   +1 more source

Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML.

open access: yesBlood
Wang Z   +23 more
europepmc   +1 more source

Discovery of PZ671, a highly potent and <i>in vivo</i> active CRBN-recruiting Bcl-xL degrader. [PDF]

open access: yesRSC Med Chem
Zhang P   +9 more
europepmc   +1 more source

Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production. [PDF]

open access: yesPLoS One
Zheng J   +11 more
europepmc   +1 more source

A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice. [PDF]

open access: yesNat Aging
Yang Y   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy